Pediatrics And Children's Health Archives

The new facility will include behavioral health and position the state as a national leader.

A phase 2 study, led by Thomas W. Ferkol, MD, at the UNC School of Medicine, demonstrates safety and efficacy of idrevloride with hypertonic saline for treatment of primary ciliary dyskinesia, a rare genetic disorder that can lead to permanent lung damage.

Jane Little, MD, and Maria Boucher, MD, both in the UNC School of Medicine, detail the current struggles of patients with sickle cell disease and how we can help.

The new observation, made by UNC School of Medicine’s Stephan Moll, MD, and Jacquelyn Baskin-Miller, MD, suggests that a life-threatening blood clotting disorder can be caused by an infection with adenovirus, one of the most common respiratory viruses in pediatric and adult patients.

Springer recently released "Chronic Illness Care, Principles and Practice," edited by UNC Family Medicine's Timothy P. Daaleman, DO, MPH, and Margaret R. Helton, MD. Faculty members in the Department of Family Medicine, faculty across the UNC-Chapel Hill campus, and other national and international experts wrote the textbook.

Bianca A. Allison, MD, MPH, assistant professor of Pediatrics at the UNC School of Medicine, led a qualitative study showing that adolescents know and care about the changing legal landscape of abortion in the United States.

For more than 35 years, the Award has been given to the physician who best embodies Fuller’s commitment to patient care, teaching, and community.

The study, called EPITOPE, led by senior author A. Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine, and contributing author Edwin Kim, MD, MS, associate professor of pediatrics in the Division of Pediatric Allergy and Immunology at the UNC School of Medicine, shows superior results in desensitizing children to peanuts. Results were recently published in the New England Journal of Medicine.

The outbreak of Covid-19 presented many dangers for children, and a new study suggests increased illicit substance ingestions were among them. Lead study author Brittany Raffa, MD, clinical instructor in the Department of Pediatrics at the UNC School of Medicine, talks with CNN Health about the overall stress and parental substance use that contributed to the increase.

Michael Kappelman, MD, MPH, was the lead PI on the clinical trial, which followed nearly 300 children with Crohn’s to evaluate how their conditions changed in response to anti-TNF biologic treatments alone or in combination with a second immune suppressive medication.

A four-year clinical trial led by Edwin Kim, MD, at the UNC School of Medicine, has found that an increased dosage of a unique type of peanut allergy immunotherapy continues to show promise for children.

A research team led by William Polacheck, PhD, at the UNC School of Medicine, has engineered a microfluidic model that mimics a rare genetic disorder affecting the structure of veins, arteries, capillaries, and lymphatic vessels.

Category: Pediatrics And Children’s Health

UNC Health Announces Plans for New N.C. Children’s Hospital

Researchers Release Results from Clinical Trial for Treatment of Primary Ciliary Dyskinesia

Sickle Cell Disease Continues to Face Underfunding, Lack of Research

Common Cold Virus Linked to Potentially Fatal Blood Clotting Disorder

UNC Department of Family Medicine Authors Second Edition of Chronic Illness Care Textbook

Adolescents are Aware of and Invested in the Potential Impacts of Abortion Restrictions, Study Says

Dellon Honored with H. Fleming Fuller Award

12 Months of Treatment with EPIT Superior to Placebo in Desensitizing Children to Peanuts

Raffa Talks With CNN Health About the Increase in Kids Treated for Illicit Substance Ingestion

Researchers Announce Findings from Landmark Clinical Trial for Pediatric Crohn’s Disease

Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting

How a New Blood-Vessel-on-a-Chip Can Help Researchers Further Understand Vascular Malformations